dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Laquente, Berta |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.contributor.author | Cristina Bugés |
dc.contributor.author | Martín, Marta |
dc.contributor.author | García, Carlos |
dc.contributor.author | Pericay, Carles |
dc.contributor.author | Verdaguer Mata, Helena |
dc.date.accessioned | 2021-09-20T13:23:36Z |
dc.date.available | 2021-09-20T13:23:36Z |
dc.date.issued | 2020-07-10 |
dc.identifier.citation | Laquente B, Macarulla T, Buges C, Martin M, Garcia C, Pericay C, et al. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice. BMC Palliat Care. 2020 Jul 10;19:103. |
dc.identifier.issn | 1472-684X |
dc.identifier.uri | https://hdl.handle.net/11351/6337 |
dc.description | Quimioteràpia contra el càncer; Qualitat de vida relacionada amb la salut; Càncer de pàncrees |
dc.description.sponsorship | This study was promoted, sponsored, and funded (including statistical and medical writing support) by Celgene. The funding body contributed to study design, data analysis, and revision of the manuscript drafts; all members of the funding body involved in this work have been included in the author list. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | BMC Palliative Care;19 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Qualitat de vida - Avaluació |
dc.subject | Pàncrees - Càncer - Quimioteràpia |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Quality of Life |
dc.subject.mesh | /psychology |
dc.title | Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12904-020-00610-4 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | calidad de vida |
dc.subject.decs | /psicología |
dc.relation.publishversion | https://doi.org/10.1186/s12904-020-00610-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Laquente B] Institut Catala d’Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Avda. De la Gran Via, 199, 08908 L’Hospitalet de Llobregat, Barcelona, Spain. [Macarulla T, Verdaguer H] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Bugés C] Institut Català d’Oncologia (ICO) – Hospital Germans Trias i Pujol, Badalona, Spain. [Martín M] Hospital de Sant Pau, Barcelona, Spain. [García C] Complejo Hospitalario de Burgos, Burgos, Spain. [Pericay C] Corporació Sanitaria Parc Taulí, Sabadell, Spain |
dc.identifier.pmid | 32650765 |
dc.identifier.wos | 000552027800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |